Don't Miss this: Getting to Know the Abecma (ide-cel) CAR T Therapy MC Community Event
The newly FDA-approved treatment, Abecma (ide-cel) CAR T Therapy, has been a popular topic of myeloma-based meetings and articles in recent months. So what will make this upcoming event in the Myeloma Crowd Community any different?
We wanted to take a more basic approach when considering the CAR T therapy. We will explore practical questions surrounding CAR T therapy such as:
- What is the treatment?
- How does it work?
- Who is it for?
- What is the procedure like?
- Who qualifies for it?
- How can you sign up?
- What is recovery like?
And to answer these questions we have multiple myeloma specialist, Dr. Nina Shah from UCSF Health. With experience in the CAR T clinical trials, Dr. Shah has a unique perspective on the treatment and will be able to share her knowledge with us in a clear and precise way.
Don't miss the chance to ask an expert your questions about this new and upcoming therapy. It could be a game-changer in your myeloma journey!